查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1601274

去肾神经设备市场：按技术、产品、疾病应用和最终用户划分 - 全球预测 2025-2030

Renal Denervation Devices Market by Technology (Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based), Products (Catheters, Nerve Modifying Agents, RF Generator), Disease Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年去肾神经装置市值为2.3629亿美元，预计到2024年将达到2.6644亿美元，复合年增长率为13.68%，预计到2030年将达到5.7985亿美元。

去肾神经装置是一种透过抑制肾动脉神经活动来治疗高血压的医疗设备，在调节血压方面发挥重要作用。这种需求是由于抗治疗性高血压的盛行率不断增加而产生的，即患者对传统药物治疗没有反应。这些设备的主要用途是降低尚未透过药物手段缓解的高血压患者的血压，从而可能降低中风、心臟病和肾衰竭的风险。最终用途通常是在医疗机构内，特别是介入心臟科。根据市场洞察，高血压病例的增加和老年人口的增加、微创手术技术的技术进步正在推动市场的强劲成长轨迹。最新的机会在于人工智慧和机器学习的集成，以提高设备的有效性和患者的客製化。医疗科技公司和医疗保健组织之间的合作也提供了一条前进的道路。然而，市场成长面临着高昂的初始成本、严格的监管核准以及临床试验结果喜忧参半的挑战，这些结果有时令人怀疑疗效。这是由于缺乏患者意识和缺乏训练有素的专家来进行干预。具有高业务成长潜力的创新领域包括开拓具有改进安全性的下一代设备、在高血压发病率迅速上升的新兴市场扩大使用，以及用于远端监测和病人参与的数位化例子包括健康技术的使用。透过先进的资料分析来了解患者的人口统计和行为也可以提高竞争力。总体而言，去肾神经支配市场的竞争是温和的，现有参与者和利基公司专注于创新以获得市场占有率。鼓励公司投资实证研究，以增强临床结果和市场可信度。

主要市场统计
基准年[2023] 2.3629亿美元
预测年份 [2024] 26644万美元
预测年份 [2030] 57985万美元
复合年增长率（%） 13.68%

市场动态：快速发展的去肾神经设备市场的关键市场洞察

供需的动态交互作用正在改变肾去神经装置市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 随着年龄的增长，郁血性慢性肾衰竭的盛行率不断增加
    • 微创手术的介绍及发展趋势
  • 市场限制因素
    • 与去肾神经装置相关的高成本
  • 市场机会
    • 肾臟去神经装置的技术进步与改进
    • 继续出版肾去神经术临床指引和增加临床评估研究数量
  • 市场挑战
    • 政府对产品核可法规严格且缺乏经验丰富的医疗保健专业人员

波特五力：驾驭去肾臟神经设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解去肾神经设备市场的外部影响

外部宏观环境因素在塑造去肾神经装置市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解去肾神经装置市场的竞争格局

对肾去神经设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵去肾神经装置市场供应商的绩效评估

FPNV 定位矩阵是评估肾臟去神经设备市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着人口老化，慢性肾衰竭的盛行率不断增加
      • 微创手术的日益普及与趋势
    • 抑制因素
      • 与去肾神经装置相关的高成本
    • 机会
      • 肾臟去神经装置的技术进步与改进
      • 肾去神经术临床指引的持续出版和临床评估研究的数量不断增加
    • 任务
      • 关于产品核可的严格政府法规和缺乏经验丰富的医疗保健专业人员
  • 市场区隔分析
    • 技术：超音波肾超音波切除技术采用率高
    • 产品：积极使用多电极导管，缩短治疗时间
    • 疾病应用：去肾神经装置在高血压治疗的使用增加
    • 最终用户：门诊护理中心偏好去肾神经装置作为微创且经济高效的解决方案
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章去肾臟神经设备市场：依技术分类

  • 微输液底座
  • 药物消融
  • 射频基地
  • 超音波基地

第七章肾臟去神经设备市场：副产品

  • 导管
    • 多电极导管
    • 单电极导管
  • 神经调节剂
  • 射频发生器

第八章去肾神经装置市场依疾病分类的应用

  • 糖尿病
  • 心臟衰竭
  • 高血压
  • 肾衰竭

第九章去肾神经装置市场：依最终用户分类

  • 门诊治疗中心
  • 诊断中心和医院
  • 研究和学术

第10章美洲去肾神经装置市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太去肾臟神经设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲去肾神经装置市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Record Medical 和 Otsuka Medical Devices 宣布首款 FDA核准的去肾神经系统用于治疗高血压
    • FDA核准Verve Medical 的 IDE 肾盂去神经术研究
    • 韩国Start-UpsKalos 获得 350 万美元津贴，用于开发治疗高血压的去肾神经装置
    • 德国正在进行超音波消融肾去超音波抗治疗性高血压的早期疗效评估
    • Andera Partners 投资了一家医疗技术公司 SoniVie，该公司正在开发一种有前途的治疗高血压的设备
    • 法国Medtronic公司生产的肾臟去神经导管 SYMPLICITY SPYRAL 过渡盖
    • 上海金叶医疗科技有限公司获数百万人民币C轮融资
    • SPYRAL HTN-ON MED 试验证明了有意义的临床益处，与其他 SPYRAL HTN 肾臟去神经试验一致
    • Sonivee 获得 FDA 的 IDE核准，用于使用肾动脉去神经 TIVUS 技术治疗高血压的先驱性研究
    • Ablative Solutions 在 D 轮资金筹措中筹集了 9,140 万美元
    • Clinical Accelerator 宣布与 Verve Medical 合作进行抗治疗性的早期人体可行性研究

公司名单

  • Abbott Laboratories
  • Ablative Solutions, Inc.
  • AngioDynamics, Inc.
  • Aria CV, Inc.
  • AtriCure, Inc.
  • Bio-Heart
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Kalos Medical
  • Medtronic PLC
  • Mercator MedSystems, Inc.
  • Otsuka Holdings Co., Ltd.
  • Shanghai Meiliweiye Medical Technology Co., Ltd.
  • SoniVie
  • Symap Medical, Ltd.
  • Symple Surgical, Inc.
  • Terumo Corporation
Product Code: MRR-957C47F91FC5

The Renal Denervation Devices Market was valued at USD 236.29 million in 2023, expected to reach USD 266.44 million in 2024, and is projected to grow at a CAGR of 13.68%, to USD 579.85 million by 2030.

Renal denervation devices are medical tools used to treat hypertension by disrupting nerve activity in the renal arteries, which play a crucial role in blood pressure regulation. Their necessity arises from the increasing prevalence of treatment-resistant hypertension, a condition where patients fail to respond to traditional medications. The primary application of these devices is in reducing blood pressure among hypertensive patients who have not found relief through pharmacological means, potentially lowering the risks of stroke, heart attack, and kidney failure. End-use is typically within healthcare facilities, specifically interventional cardiology departments. Market insights reveal a robust growth trajectory fueled by rising hypertension cases and a growing geriatric population, coupled with technological advancements in minimally invasive surgical techniques. The latest opportunities lie in the integration of AI and machine learning to enhance device efficacy and patient customization. Collaborations between medical technology companies and healthcare institutions also offer pathways for advancements. However, market growth is challenged by high initial costs, stringent regulatory approvals, and the mixed results from clinical trials that occasionally question efficacy. In this context, limitations involve a lack of awareness among patients and a deficiency in skilled personnel trained to perform the interventions. Innovative areas with high potential for business growth include the development of next-generation devices with improved safety profiles, expanding use in emerging markets where hypertension rates are skyrocketing, and leveraging digital health technologies for remote monitoring and patient engagement. Understanding patient demographics and behavior through advanced data analytics can also provide a competitive edge. Overall, the renal denervation market is moderately competitive, with a blend of established players and niche companies focusing on innovation to claim market share. Companies are advised to invest in evidence-based research to strengthen clinical outcomes and market credibility.

KEY MARKET STATISTICS
Base Year [2023] USD 236.29 million
Estimated Year [2024] USD 266.44 million
Forecast Year [2030] USD 579.85 million
CAGR (%) 13.68%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Renal Denervation Devices Market

The Renal Denervation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of congestive chronic renal failure with aging population
    • Growing adoption and inclination towards minimally invasive surgical procedures
  • Market Restraints
    • High cost associated with renal denervation devices
  • Market Opportunities
    • Technological advancements and improvements in renal denervation devices
    • Ongoing publishing of clinical guidelines for renal denervation and increasing clinical assessment studies
  • Market Challenges
    • Strict government regulations for product approval coupled with lack of experienced healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Renal Denervation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Renal Denervation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Renal Denervation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Renal Denervation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Renal Denervation Devices Market

A detailed market share analysis in the Renal Denervation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Renal Denervation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Renal Denervation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Renal Denervation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., AngioDynamics, Inc., Aria CV, Inc., AtriCure, Inc., Bio-Heart, Boston Scientific Corporation, Cardinal Health, Inc., Kalos Medical, Medtronic PLC, Mercator MedSystems, Inc., Otsuka Holdings Co., Ltd., Shanghai Meiliweiye Medical Technology Co., Ltd., SoniVie, Symap Medical, Ltd., Symple Surgical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Renal Denervation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based, and Ultrasound-Based.
  • Based on Products, market is studied across Catheters, Nerve Modifying Agents, and RF Generator. The Catheters is further studied across Multi Electrode Catheter and Single Electrode Catheter.
  • Based on Disease Application, market is studied across Diabetes, Heart Failure, Hypertension, and Renal Failure.
  • Based on End-User, market is studied across Ambulatory Care Centers, Diagnostic Centers & Hospitals, and Research & Academia.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of congestive chronic renal failure with aging population
      • 5.1.1.2. Growing adoption and inclination towards minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with renal denervation devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and improvements in renal denervation devices
      • 5.1.3.2. Ongoing publishing of clinical guidelines for renal denervation and increasing clinical assessment studies
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulations for product approval coupled with lack of experienced healthcare professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: High adoption of ultrasound-based renal denervation technology
    • 5.2.2. Product: Significant use of multi-electrode catheters for their shorter-time of procedures
    • 5.2.3. Disease Application: Proliferating use of renal denervation devices for treating hypertension
    • 5.2.4. End-User: Ambulatory care centers prioritize renal denervation devices as a minimally invasive and cost-effective solution
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Renal Denervation Devices Market, by Technology

  • 6.1. Introduction
  • 6.2. Micro-Infusion-Based
  • 6.3. Pharmacologic Ablation
  • 6.4. Radiofrequency-Based
  • 6.5. Ultrasound-Based

7. Renal Denervation Devices Market, by Products

  • 7.1. Introduction
  • 7.2. Catheters
    • 7.2.1. Multi Electrode Catheter
    • 7.2.2. Single Electrode Catheter
  • 7.3. Nerve Modifying Agents
  • 7.4. RF Generator

8. Renal Denervation Devices Market, by Disease Application

  • 8.1. Introduction
  • 8.2. Diabetes
  • 8.3. Heart Failure
  • 8.4. Hypertension
  • 8.5. Renal Failure

9. Renal Denervation Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Care Centers
  • 9.3. Diagnostic Centers & Hospitals
  • 9.4. Research & Academia

10. Americas Renal Denervation Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Renal Denervation Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Renal Denervation Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
    • 13.3.2. FDA Approves Verve Medical's IDE Renal Pelvic Denervation Trial
    • 13.3.3. Korean Startup Kalos Gets USD 3.5 Million Grant to Develop Renal Denervation Device for hypertension Treatment
    • 13.3.4. Renal Denervation Using Ultrasound Ablation in Treatment-Resistant Hypertension is Being Evaluated for Early Benefit Assessment in Germany
    • 13.3.5. Andera Partners Invests in SoniVie, a Medtech Company Developing a Promising Device for the Treatment of Hypertension
    • 13.3.6. Transitional Coverage for Renal Denervation Catheter SYMPLICITY SPYRAL from Medtronic in France
    • 13.3.7. Shanghai Golden Leaf Med Tec Co., Ltd Secures Hundreds of Mns of CNY in Series C Round
    • 13.3.8. SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with other SPYRAL HTN Renal Denervation Trials
    • 13.3.9. SoniVie Receives IDE Approval from FDA for its Pilot Study to Treat Hypertension with its Renal Artery Denervation TIVUS Technology
    • 13.3.10. Ablative Solutions Raises USD 91.4 Million in Series D Financing Round
    • 13.3.11. Clinical Accelerator Announces Collaboration with Verve Medical to Conduct an Early Human Feasibility Study for Treatment-Resistant Hypertension

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Ablative Solutions, Inc.
  • 3. AngioDynamics, Inc.
  • 4. Aria CV, Inc.
  • 5. AtriCure, Inc.
  • 6. Bio-Heart
  • 7. Boston Scientific Corporation
  • 8. Cardinal Health, Inc.
  • 9. Kalos Medical
  • 10. Medtronic PLC
  • 11. Mercator MedSystems, Inc.
  • 12. Otsuka Holdings Co., Ltd.
  • 13. Shanghai Meiliweiye Medical Technology Co., Ltd.
  • 14. SoniVie
  • 15. Symap Medical, Ltd.
  • 16. Symple Surgical, Inc.
  • 17. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. RENAL DENERVATION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. RENAL DENERVATION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. RENAL DENERVATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. RENAL DENERVATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RENAL DENERVATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. RENAL DENERVATION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MICRO-INFUSION-BASED, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PHARMACOLOGIC ABLATION, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RADIOFREQUENCY-BASED, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MULTI ELECTRODE CATHETER, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY SINGLE ELECTRODE CATHETER, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY NERVE MODIFYING AGENTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RF GENERATOR, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RENAL FAILURE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 26. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & HOSPITALS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 28. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 29. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 30. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 31. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 32. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 33. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 34. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 35. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 36. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 37. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 38. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 39. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 40. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 41. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 42. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 43. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 44. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 45. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 46. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 47. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 48. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 49. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 50. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 51. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 52. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 53. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 54. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 55. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 56. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 57. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 58. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 59. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 60. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 61. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 62. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 63. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 64. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 65. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 66. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 67. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 68. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 69. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 70. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 71. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 72. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 73. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 74. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 75. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 76. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 77. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 78. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 79. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 80. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 81. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 82. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 83. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 84. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 85. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 86. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 87. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 88. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 89. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 90. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 91. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 92. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 93. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 94. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 95. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 96. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 97. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 98. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 99. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 100. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 101. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 102. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 103. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 104. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 105. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 106. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 107. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 108. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 109. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 110. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 111. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 112. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 113. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 114. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 115. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 116. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 117. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 118. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 119. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 120. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 121. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 122. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 123. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 124. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 125. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 132. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 133. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 134. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 135. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 136. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 137. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 138. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 139. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 140. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 141. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 142. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 143. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 144. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 145. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 146. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 147. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 148. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 149. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 150. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 151. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 152. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 153. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 154. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 155. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 156. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 157. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 158. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 159. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 160. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 161. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 162. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 163. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 164. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 165. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 166. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 167. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 168. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 169. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 170. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 171. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 172. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 173. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 174. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 175. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 176. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 177. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 178. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 179. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 180. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 181. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 182. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 183. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 184. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 185. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 186. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 187. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 188. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 189. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 190. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 191. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 192. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 193. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 194. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 195. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 196. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 197. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 198. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 199. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 200. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 201. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 202. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 203. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 204. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 205. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 206. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 207. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 208. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 209. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 210. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 211. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 212. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 213. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 214. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 215. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 216. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 217. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 218. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 219. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 220. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 221. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 222. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 223. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 224. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 225. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 226. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 227. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 228. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 229. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 230. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 231. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 232. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
  • TABLE 233. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
  • TABLE 234. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
  • TABLE 235. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 236. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 237. RENAL DENERVATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. RENAL DENERVATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023